Müller cells trophism and pathology as the next therapeutic targets for retinal diseases.
Progress in Retinal and Eye Research,
Journal Year:
2025,
Volume and Issue:
unknown, P. 101357 - 101357
Published: April 1, 2025
Language: Английский
Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 22, 2025
Abstract
Glaucoma
polygenic
risk
scores
(PRS)
effectively
identify
disease
risk,
but
some
individuals
with
high
PRS
do
not
develop
glaucoma.
Factors
contributing
to
this
resilience
remain
unclear.
Using
4,658
glaucoma
cases
and
113,040
controls
in
a
cross-sectional
study
the
UK
Biobank,
we
investigated
whether
plasma
metabolites
enhanced
prediction
if
metabolomic
signature
of
high-genetic
existed.
Logistic
regression
models
incorporating
168
NMR-based
into
PRS-based
assessments
were
developed,
multiple
comparison
corrections
applied.
While
weakly
predicted
(Area
Under
Curve=0.579),
they
offered
modest
improvement
PRS-only-based
(P=0.004).
We
identified
associated
top
decile,
elevated
glycolysis-related
metabolites—lactate
(P=8.8E-12),
pyruvate
(P=1.9E-10),
citrate
(P=0.02)—linked
reduced
prevalence.
These
combined
significantly
modified
PRS-glaucoma
relationship
(P
interaction
=0.011).
Higher
total
metabolite
levels
within
highest
quartile
corresponded
lower
prevalence
(Odds
Ratio
vs.
lowest
=0.71,
95%
Confidence
Interval
[CI]=0.64–0.80).
As
is
foundational
linking
glycolysis
tricarboxylic
acid
cycle
metabolism
ATP
generation,
pursued
experimental
validation
for
putative
biomarker
human-relevant
Mus
musculus
model.
Dietary
mitigated
intraocular
pressure
(P=0.002)
optic
nerve
damage
(P<0.0003)
Lmx1b
V265D
mice.
findings
highlight
protective
role
pyruvate-related
against
suggest
potential
avenues
therapeutic
intervention.
Language: Английский
Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Published: March 11, 2025
A
glaucoma
polygenic
risk
score
(PRS)
can
effectively
identify
disease
risk,
but
some
individuals
with
high
PRS
do
not
develop
glaucoma.
Factors
contributing
to
this
resilience
remain
unclear.
Using
4,658
cases
and
113,040
controls
in
a
cross-sectional
study
of
the
UK
Biobank,
we
investigated
whether
plasma
metabolites
enhanced
prediction
if
metabolomic
signature
high-genetic-risk
existed.
Logistic
regression
models
incorporating
168
NMR-based
into
PRS-based
assessments
were
developed,
multiple
comparison
corrections
applied.
While
weakly
predicted
(Area
Under
Curve
=
0.579),
they
offered
marginal
improvement
PRS-only-based
(p=0.004).
We
identified
associated
top
decile,
elevated
glycolysis-related
metabolites-lactate
(p=8.8E-12),
pyruvate
(p=1.9E-10),
citrate
(p=0.02)-linked
reduced
prevalence.
These
combined
significantly
modified
PRS-glaucoma
relationship
(Pinteraction
0.011).
Higher
total
metabolite
levels
within
highest
quartile
corresponded
lower
prevalence
(Odds
Ratiohighest
vs.
lowest
quartile=0.71,
95%
Confidence
Interval
0.64-0.80).
As
is
foundational
linking
glycolysis
tricarboxylic
acid
cycle
metabolism
ATP
generation,
pursued
experimental
validation
for
putative
biomarker
human-relevant
Mus
musculus
model.
Dietary
mitigated
intraocular
pressure
(p=0.002)
optic
nerve
damage
(p<0.0003)
Lmx1bV265D
mice.
findings
highlight
protective
role
pyruvate-related
against
suggest
potential
avenues
therapeutic
intervention.
Language: Английский
Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Published: March 11, 2025
Glaucoma
polygenic
risk
scores
(PRS)
effectively
identify
disease
risk,
but
some
individuals
with
high
PRS
do
not
develop
glaucoma.
Factors
contributing
to
this
resilience
remain
unclear.
Using
4,658
glaucoma
cases
and
113,040
controls
in
a
cross-sectional
study
the
UK
Biobank,
we
investigated
whether
plasma
metabolites
enhanced
prediction
if
metabolomic
signature
of
high-genetic
existed.
Logistic
regression
models
incorporating
168
NMR-based
into
PRS-based
assessments
were
developed,
multiple
comparison
corrections
applied.
While
weakly
predicted
(Area
Under
Curve=0.579),
they
offered
modest
improvement
PRS-only-based
(P=0.004).
We
identified
associated
top
decile,
elevated
glycolysis-related
metabolites—lactate
(P=8.8E-12),
pyruvate
(P=1.9E-10),
citrate
(P=0.02)—linked
reduced
prevalence.
These
combined
significantly
modified
PRS-glaucoma
relationship
(P
interaction
=0.011).
Higher
total
metabolite
levels
within
highest
quartile
corresponded
lower
prevalence
(Odds
Ratio
vs.
lowest
=0.71,
95%
Confidence
Interval
[CI]=0.64–0.80).
As
is
foundational
linking
glycolysis
tricarboxylic
acid
cycle
metabolism
ATP
generation,
pursued
experimental
validation
for
putative
biomarker
human-relevant
Mus
musculus
model.
Dietary
mitigated
intraocular
pressure
(P=0.002)
optic
nerve
damage
(P<0.0003)
Lmx1b
V265D
mice.
findings
highlight
protective
role
pyruvate-related
against
suggest
potential
avenues
therapeutic
intervention.
Language: Английский
Pyruvate and Related Energetic Metabolites Modulate Resilience Against High Genetic Risk for Glaucoma
Published: March 28, 2025
A
glaucoma
polygenic
risk
score
(PRS)
can
effectively
identify
disease
risk,
but
some
individuals
with
high
PRS
do
not
develop
glaucoma.
Factors
contributing
to
this
resilience
remain
unclear.
Using
4,658
cases
and
113,040
controls
in
a
cross-sectional
study
of
the
UK
Biobank,
we
investigated
whether
plasma
metabolites
enhanced
prediction
if
metabolomic
signature
high-genetic-risk
existed.
Logistic
regression
models
incorporating
168
NMR-based
into
PRS-based
assessments
were
developed,
multiple
comparison
corrections
applied.
While
weakly
predicted
(Area
Under
Curve=0.579),
they
offered
marginal
improvement
PRS-only-based
(P=0.004).
We
identified
associated
top
decile,
elevated
glycolysis-related
metabolites—lactate
(P=8.8E-12),
pyruvate
(P=1.9E-10),
citrate
(P=0.02)—linked
reduced
prevalence.
These
combined
significantly
modified
PRS-glaucoma
relationship
(P
interaction
=0.011).
Higher
total
metabolite
levels
within
highest
quartile
corresponded
lower
prevalence
(Odds
Ratio
vs.
lowest
=0.71,
95%
Confidence
Interval=0.64–0.80).
As
is
foundational
linking
glycolysis
tricarboxylic
acid
cycle
metabolism
ATP
generation,
pursued
experimental
validation
for
putative
biomarker
human-relevant
Mus
musculus
model.
Dietary
mitigated
intraocular
pressure
(P=0.002)
optic
nerve
damage
(P<0.0003)
Lmx1b
V265D
mice.
findings
highlight
protective
role
pyruvate-related
against
suggest
potential
avenues
therapeutic
intervention.
Language: Английский
Pyruvate and related energetic metabolites modulate resilience against high genetic risk for glaucoma
eLife,
Journal Year:
2025,
Volume and Issue:
14
Published: April 24, 2025
A
glaucoma
polygenic
risk
score
(PRS)
can
effectively
identify
disease
risk,
but
some
individuals
with
high
PRS
do
not
develop
glaucoma.
Factors
contributing
to
this
resilience
remain
unclear.
Using
4,658
cases
and
113,040
controls
in
a
cross-sectional
study
of
the
UK
Biobank,
we
investigated
whether
plasma
metabolites
enhanced
prediction
if
metabolomic
signature
high-genetic-risk
existed.
Logistic
regression
models
incorporating
168
NMR-based
into
PRS-based
assessments
were
developed,
multiple
comparison
corrections
applied.
While
weakly
predicted
(Area
Under
Curve
=
0.579),
they
offered
marginal
improvement
PRS-only-based
(p=0.004).
We
identified
associated
top
decile,
elevated
glycolysis-related
metabolites—lactate
(p=8.8E-12),
pyruvate
(p=1.9E-10),
citrate
(p=0.02)—linked
reduced
prevalence.
These
combined
significantly
modified
PRS-glaucoma
relationship
(P
interaction
0.011).
Higher
total
metabolite
levels
within
highest
quartile
corresponded
lower
prevalence
(Odds
Ratio
vs.
lowest
=0.71,
95%
Confidence
Interval
0.64–0.80).
As
is
foundational
linking
glycolysis
tricarboxylic
acid
cycle
metabolism
ATP
generation,
pursued
experimental
validation
for
putative
biomarker
human-relevant
Mus
musculus
model.
Dietary
mitigated
intraocular
pressure
(p=0.002)
optic
nerve
damage
(p<0.0003)
Lmx1b
V265D
mice.
findings
highlight
protective
role
pyruvate-related
against
suggest
potential
avenues
therapeutic
intervention.
Language: Английский
Age-Related Changes in the Glycolytic Enzymes of M2-Isoform of Pyruvate Kinase and Fructose-1,6-Bisphosphate Aldolase: Implications to Age-Related Macular Degeneration
Aging and Disease,
Journal Year:
2024,
Volume and Issue:
15(5), P. 2271 - 2271
Published: Jan. 1, 2024
Prior
studies
have
emphasized
a
bioenergetic
crisis
in
the
retinal
pigment
epithelium
(RPE)
as
critical
factor
development
of
age-related
macular
degeneration
(AMD).
The
isoforms
Fructose-1,6-bisphosphate
aldolase
C
(ALDOC)
and
pyruvate
kinase
M2
(PKM2)
been
proposed
to
play
role
AMD
pathogenesis.
While
PKM2
ALDOC
are
crucial
for
aerobic
glycolysis
neural
retina,
they
not
essential
RPE.
In
this
study,
we
examined
expression
activity
both
young
aged
RPE
cells,
well
retina
tissue
mice,
including
an
experimentally
induced
mouse
model.
Our
findings
reveal
upregulation
expression,
accompanied
by
increased
activity,
Conversely,
there
is
decrease
but
increase
retina.
Overall,
our
study
indicates
that
cells
tend
favor
glycolysis,
while
tendency
diminished
These
results
underscore
significance
targeting
promising
therapeutic
approach
address
prevent
vision
loss
AMD.
Language: Английский